Patents by Inventor Xingjie Chen

Xingjie Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11488790
    Abstract: Embodiments of the present disclosure relate to a switch device, comprising: a first three-position switch; a second three-position switch disposed below the first three-position switch; a circuit breaker disposed between the first three-position switch and the second three-position switch. A first interlock unit is disposed above the circuit breaker and connected to the circuit breaker and the first three-position switch, and configured to block a manual operation of the first three-position switch in a closed state of the circuit breaker, and configured to block a manual closing operation of the circuit breaker while the first three-position switch is manually operated in an open state of the circuit breaker.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: November 1, 2022
    Assignee: ABB SCHWEIZ AG
    Inventors: Congming Yan, Xingjie Chen, Liqun Huang, Huihuang Yang, Ziying Xiao
  • Publication number: 20220172908
    Abstract: Embodiments of the present disclosure relate to a switch device, comprising: a first three-position switch; a second three-position switch disposed below the first three-position switch; a circuit breaker disposed between the first three-position switch and the second three-position switch. A first interlock unit is disposed above the circuit breaker and connected to the circuit breaker and the first three-position switch, and configured to block a manual operation of the first three-position switch in a closed state of the circuit breaker, and configured to block a manual closing operation of the circuit breaker while the first three-position switch is manually operated in an open state of the circuit breaker.
    Type: Application
    Filed: February 10, 2021
    Publication date: June 2, 2022
    Inventors: Congming Yan, Xingjie Chen, Liqun Huang, Huihuang Yang, Ziying Xiao
  • Publication number: 20100234578
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: March 23, 2010
    Publication date: September 16, 2010
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Patent number: 7537763
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: May 26, 2009
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20090123466
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: October 6, 2008
    Publication date: May 14, 2009
    Inventors: TOSHIFUMI MIKAYAMA, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20070077242
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: December 5, 2006
    Publication date: April 5, 2007
    Applicant: Kirin Beer Kabushiki Kaisha
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker Force, Xingjie Chen, Nobuaki Takahashi
  • Patent number: 7193064
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: March 20, 2007
    Assignee: Kirin Beer Kabushiki Kaisha
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Patent number: 7063845
    Abstract: The invention is directed to human antibodies that bind CD40 (e.g., human CD40), methods of producing the antibodies and methods of use. Invention human CD40 antibodies include antibodies that can modulate one or more activities of CD40, such as increasing or decreasing cell proliferation. Invention human CD40 antibodies are therefore useful for increasing or decreasing a CD40 activity in order to alter CD40 activity in vivo.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: June 20, 2006
    Assignees: Gemini Science, Inc., La Jolla Institute for Allergy & Immunology
    Inventors: Toshifumi Mikayama, Nobuaki Takahashi, Xingjie Chen, Stephen P. Schoenberger
  • Publication number: 20040120948
    Abstract: An antibody or a functional fragment thereof, acting agonistically or antagonistically on CD40.
    Type: Application
    Filed: October 23, 2003
    Publication date: June 24, 2004
    Inventors: Toshifumi Mikayama, Hitoshi Yoshida, Walker R. Force, Xingjie Chen, Nobuaki Takahashi
  • Publication number: 20020142358
    Abstract: The invention is directed to human antibodies that bind CD40 (e.g., human CD40), methods of producing the antibodies and methods of use. Invention human CD40 antibodies include antibodies that can modulate one or more activities of CD40, such as increasing or decreasing cell proliferation. Invention human CD40 antibodies are therefore useful for increasing or decreasing a CD40 activity in order to alter CD40 activity in vivo.
    Type: Application
    Filed: April 27, 2001
    Publication date: October 3, 2002
    Inventors: Toshifumi Mikayama, Nobuaki Takahashi, Xingjie Chen, Stephen P. Schoenberger